Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Intangibles (2020 - 2025)

Agilon Health's Intangibles history spans 6 years, with the latest figure at $65.7 million for Q4 2025.

  • For Q4 2025, Intangibles fell 9.68% year-over-year to $65.7 million; the TTM value through Dec 2025 reached $65.7 million, down 9.68%, while the annual FY2025 figure was $65.7 million, 9.68% down from the prior year.
  • Intangibles reached $65.7 million in Q4 2025 per AGL's latest filing, down from $75.3 million in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $158.3 million in Q1 2023 to a low of $18.4 million in Q4 2022.
  • Average Intangibles over 5 years is $80.3 million, with a median of $73.1 million recorded in 2024.
  • Peak YoY movement for Intangibles: plummeted 66.7% in 2022, then soared 245.67% in 2023.
  • A 5-year view of Intangibles shows it stood at $55.4 million in 2021, then tumbled by 66.7% to $18.4 million in 2022, then skyrocketed by 245.67% to $63.8 million in 2023, then grew by 14.12% to $72.8 million in 2024, then decreased by 9.68% to $65.7 million in 2025.
  • Per Business Quant, the three most recent readings for AGL's Intangibles are $65.7 million (Q4 2025), $75.3 million (Q3 2025), and $65.6 million (Q2 2025).